Leukoplakia

Search with Google Search with Bing
Information
Disease name
Leukoplakia
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04267419 Completed Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions February 18, 2019 December 15, 2019
NCT00179361 Completed Natural History of Oro-pharyngeal Cancer Precursors November 2004 July 2014
NCT00571974 Completed Phase 1/Phase 2 Treatment of Oral Premalignant Lesions With 5-ALA PDT January 2007 January 2012
NCT01497951 Completed Phase 3 Photodynamic Therapy for Oral Precursor Lesions May 2011 January 2017
NCT00001698 Completed Phase 2 Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR June 1998 June 2004
NCT05323292 Enrolling by invitation Vitamin A Status in Patients With Vocal Fold Leukoplakia June 29, 2022 December 31, 2026
NCT06325514 Not yet recruiting Artificial Intelligence Based Program to Classify Oral Cavity Findings Based on Clinical Image Analysis April 1, 2024 September 1, 2024
NCT03603223 Recruiting Phase 2 Pembrolizumab in Treating Participants With Leukoplakia May 3, 2019 June 1, 2025
NCT05536037 Terminated Phase 1 Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions May 4, 2022 March 16, 2024
NCT03990636 Unknown status Phase 2 Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial October 17, 2019 December 15, 2021
NCT02737176 Unknown status N/A Tobacco Cessation Intervention Study for Oral Diseases April 2016 December 2018
MeSH unique ID (MeSH (Medical Subject Headings))
D007971